BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1045 related articles for article (PubMed ID: 18783877)

  • 1. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
    Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
    Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Korfage IJ
    Eur Urol; 2009 Feb; 55(2):432. PubMed ID: 18783875
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Gattellari M; Ward JE
    Eur Urol; 2009 Feb; 55(2):431. PubMed ID: 18783873
    [No Abstract]   [Full Text] [Related]  

  • 5. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life after radical prostatectomy or watchful waiting.
    Steineck G; Helgesen F; Adolfsson J; Dickman PW; Johansson JE; Norlén BJ; Holmberg L;
    N Engl J Med; 2002 Sep; 347(11):790-6. PubMed ID: 12226149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.
    Holmberg L; Bill-Axelson A; Helgesen F; Salo JO; Folmerz P; Häggman M; Andersson SO; Spångberg A; Busch C; Nordling S; Palmgren J; Adami HO; Johansson JE; Norlén BJ;
    N Engl J Med; 2002 Sep; 347(11):781-9. PubMed ID: 12226148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.
    Bill-Axelson A; Garmo H; Holmberg L; Johansson JE; Adami HO; Steineck G; Johansson E; Rider JR
    Eur Urol; 2013 Dec; 64(6):920-8. PubMed ID: 23465517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer.
    Bacon CG; Giovannucci E; Testa M; Kawachi I
    J Urol; 2001 Nov; 166(5):1804-10. PubMed ID: 11586228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical prostatectomy versus watchful waiting in early prostate cancer.
    Bill-Axelson A; Holmberg L; Ruutu M; Häggman M; Andersson SO; Bratell S; Spångberg A; Busch C; Nordling S; Garmo H; Palmgren J; Adami HO; Norlén BJ; Johansson JE;
    N Engl J Med; 2005 May; 352(19):1977-84. PubMed ID: 15888698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
    Di Lorenzo G; Perdonà S; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Autorino R
    J Urol; 2005 Dec; 174(6):2197-203. PubMed ID: 16280763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: quality of life in high-risk prostate cancer patients.
    Kang SH; Kim JW; Bae JH; Park HS; Moon DG; Yoon DK; Cheon J; Kim JJ
    Asian J Androl; 2006 Sep; 8(5):629-36. PubMed ID: 16847531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental health in men treated for early stage prostate carcinoma: a posttreatment, longitudinal quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor.
    Litwin MS; Lubeck DP; Spitalny GM; Henning JM; Carroll PR
    Cancer; 2002 Jul; 95(1):54-60. PubMed ID: 12115317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate.
    Wasson JH; Reda DJ; Bruskewitz RC; Elinson J; Keller AM; Henderson WG
    N Engl J Med; 1995 Jan; 332(2):75-9. PubMed ID: 7527493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in Japanese men with localized prostate cancer: assessment with the SF-8.
    Sugimoto M; Takegami M; Suzukamo Y; Fukuhara S; Kakehi Y
    Int J Urol; 2008 Jun; 15(6):524-8. PubMed ID: 18422571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma.
    Fowler FJ; McNaughton Collins M; Walker Corkery E; Elliott DB; Barry MJ
    Cancer; 2002 Jul; 95(2):287-95. PubMed ID: 12124828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
    Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.